Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Moatazedi currently holds 604,700 shares of OBALON THERAPEUTICS INC (OBLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Moatazedi has been a net seller of OBLN stock. They have purchased $0 and sold $13.0M worth of shares.
David Moatazedi's most recent insider trade was on Mar 20, 2026, when they sold 13,669 shares at $4.75 per share.
David Moatazedi serves as Executive at OBALON THERAPEUTICS INC (OBLN). They have executed 43 insider transactions totaling $13.0M over their tenure at the company.
David Moatazedi holds the position of Executive at OBALON THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
David Moatazedi has shown a selling trading pattern, with $0 in total purchases and $13.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Moatazedi was on Jun 6, 2024, when they sold $2.2M worth of EOLS shares. This transaction involved 175,940 shares at $12.59 per share.
David Moatazedi currently owns 604,700 shares of OBALON THERAPEUTICS INC (OBLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Moatazedi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Moatazedi has 43 Form 4 filings on record as an insider at OBALON THERAPEUTICS INC.
Set alerts for David Moatazedi and 40,000+ other insiders.